Thank you to our speakers, sponsors, and delegates who joined us in July 2025 for the summit! If you are interested in the 2026 event, please register your interest below to receive updates on the meeting...
The Process Development for Cell Therapies Summit 2025
Driving Process Robustness, Scalability, Speed & Affordability
The cell therapy landscape has rapidly evolved, driven by technological advancements, a surge in late-stage programs, and increasing cost pressures. As therapies have become more complex and regulatory demands have risen, there was an urgent need for refined process development strategies to accelerate the delivery of consistent, cost-effective therapies to patients.
The Process Development for Cell Therapies Summit 2025 heard from 24+ industry leaders from biopharma and service providers as they shared their best practices for driving process robustness, scalability, speed, and affordability. They gained insights into how to develop consistent, scalable, and cost-effective solutions for both autologous and allogeneic cell therapies.
They engaged with 70+ process development specialists and professionals from MSAT, QC, and CMC to address the most pressing PD bottlenecks and streamline the transition from early to late-stage development. They gained technical and strategic insights to enhance scalability and ensure regulatory readiness, helping them position their therapy for long-term commercial success.
They explored the latest innovations from Galapagos, Takeda, Cellectis, and Arsenal Bio and they shared real-world case studies on transformative tools and technologies, including automated closed-system manufacturing, workflow digitization, and artificial intelligence.
2025 PROGRAM
World-Class Speakers for 2025 Included
Previously Attending Companies Include:
What Your Peers Had to Say:
"It's high time that Process Development professionals come together and share key ideas and insights so that the entire industry can advance based on the achievements of these skilled individuals."
– 2025 Speaker, Senior Engineer, TG Therapeutics
"Unlike many events that focus solely on breakthrough tech, this one addressed the practical realities of scaling and reproducibility—giving valuable insight into both shared and modality-specific challenges in cell therapy.”
– 2024 Attendee, Senior Engineer, Arsenal Bio
“It was great to connect with other process development professionals and realize that many of the optimizations and challenges we’ve faced are shared across the industry.”
– 2024 Speaker, Senior Scientist, Immatics
2025 Partners:
Lead Partner:
Expertise Partner:
Expertise Partner:
Exhibition Partner:
Hosting Partner:
